Sign in or Register   Sign in or Register
  |  

Mouse Anti-BSCL2 Recombinant Antibody (1G4) (CBMAB-A0889-LY)

The product is antibody recognizes BSCL2. The antibody 1G4 immunoassay techniques such as: WB, ELISA.
See all BSCL2 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
1G4
Antibody Isotype
IgG1, κ
Application
WB, ELISA

Basic Information

Immunogen
BSCL2 (NP_116056, 259 a.a. ~ 357 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
BSCL2, Seipin Lipid Droplet Biogenesis Associated
Introduction
This gene encodes protein seipin, which is located in the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
Entrez Gene ID
26580
UniProt ID
Q96G97
Alternative Names
GNG3LG; HMN5; MGC4694; SPG17
Function
Plays a crucial role in the formation of lipid droplets (LDs) which are storage organelles at the center of lipid and energy homeostasis (PubMed:19278620, PubMed:21533227, PubMed:31708432, PubMed:30293840).
In association with TMEM159/LDAF1, defines the sites of LD formation in the ER (PubMed:31708432).
Also required for growth and maturation of small nascent LDs into larger mature LDs (PubMed:27564575).
Mediates the formation and/or stabilization of endoplasmic reticulum-lipid droplets (ER-LD) contacts, facilitating protein and lipid delivery from the ER into growing LDs (PubMed:31178403, PubMed:27879284).
Regulates the maturation of ZFYVE1-positive nascent LDs and the function of the RAB18-ZFYVE1 complex in mediating the formation of ER-LD contacts (PubMed:30970241).
Binds anionic phospholipids including phosphatidic acid (PubMed:30293840).
Plays an important role in the differentiation and development of adipocytes (By similarity).
Biological Process
Fat cell differentiation Source: UniProtKB
Lipid catabolic process Source: UniProtKB-KW
Lipid droplet formation Source: UniProtKB
Lipid droplet organization Source: UniProtKB
Lipid storage Source: UniProtKB
Negative regulation of lipid catabolic process Source: UniProtKB
Positive regulation of cold-induced thermogenesis Source: YuBioLab
Cellular Location
Endoplasmic reticulum membrane; Lipid droplet. Localizes at endoplasmic reticulum-lipid droplets (ER-LD) contact sites.
Involvement in disease
Congenital generalized lipodystrophy 2 (CGL2): An autosomal recessive disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.
Spastic paraplegia 17, autosomal dominant (SPG17): A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG17 is characterized by prominent amyotrophy of the hand muscles, the presence of mild to severe pyramidal tract signs and spastic paraplegia. SPG17 is a motor neuron disease overlapping with distal spinal muscular atrophy type 5.
Neuronopathy, distal hereditary motor, 5C (HMN5C): A form of distal hereditary motor neuronopathy, a heterogeneous group of neuromuscular diseases caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. HMN5C is characterized by distal muscular atrophy primarily affecting the upper limbs. Lower limb involvement may occur at the same time or later. Clinical features are highly variable even within families, and include poor fine hand motor skills, difficulty walking, foot deformities, spasticity and hyperreflexia. Some HMN5C patients show axonal peripheral neuropathy and distal sensory impairment. HMN5C inheritance is autosomal dominant with incomplete penetrance.
Encephalopathy, progressive, with or without lipodystrophy (PELD): A neurodegenerative disease characterized by developmental regression of motor and cognitive skills in the first years of life, often leading to death in the first decade, hyperactive behavior, seizures, tremor and ataxic gait. Patients may show a mild or typical lipodystrophic appearance.
Topology
Cytoplasmic: 1-26 aa
Helical: 27-47 aa
Lumenal: 48-242 aa
Helical: 243-263 aa
Cytoplasmic: 264-398 aa
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-BSCL2 Recombinant Antibody (1G4)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare